Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Cegedim SA is a French company specializing in the healthcare technology and services industry. It provides software, databases, and services to healthcare professionals, insurers, and pharmaceutical companies, focusing on solutions that enhance operational efficiency and data management. The company offers products such as customer relationship management (CRM) solutions, electronic health records, and healthcare data analytics. Founded in 1969, Cegedim is headquartered in Boulogne-Billancourt, France, with operations extending across multiple countries. It holds a competitive position through its comprehensive suite of integrated solutions tailored for the healthcare sector.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Cegedim SAEli Lilly
Last price
€9.65$1,427.28
Currency
EUR
USD
€133M$1.3T
9.7546.65
€0.99$30.81
0.570.39
0$6.69
00.48%
Sector
HealthHealth
Employees
6,49250,000
Ticker
€CGM$LLY
Primary listing
PARNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €CGM or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.